Stock·NASDAQ·Healthcare
Tilray Brands Inc. (TLRY)
- Market cap
- $401.98M
- Dividend yield
- None
- Street target
- $4.50median of 10 analysts
- 52-week range
- $2.68 $15.70
TLRY stock forecast today
Where TLRY stands today, and what CleaRank Financial AI makes of it.
TLRY at a glance
Tilray Brands Inc. (TLRY): Sell, 39/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($3.95 and $5.61).
- Insiders Insiders sold $233K and bought $193K over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Tilray Brands Inc. (TLRY) Sell, with a model score of 39/100.
The trend holds it back most: the price is 51.49% below its 200-day average and 31.07% below its 50-day average, and the 50-day average is 29.62% below the 200-day. The 50-day average stands at $3.95 and the 200-day at $5.61. Over the past year the price fell 81.74%.
Only on CleaRank
Figures we compute ourselves from TLRY's own price, earnings and insider-filing history. Tap one to see it in context.
TLRY stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $2.72 is 31.1% below the 50-day simple moving average of $3.95.Price above its 200-day average ›
The price is 51.5% below the 200-day simple moving average of $5.61.50-day average above the 200-day ›
The 50-day average ($3.95) is 29.6% below the 200-day average ($5.61), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 0% of its 52-week range, between $2.68 and $15.70.
TLRY share price
Pick a period: each tab shows how far TLRY has moved over it, to the last close.
Today's trading
Where TLRY sits inside today's range and its 52-week range.
TLRY fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/2P/S below the sector median ›
The price-to-sales ratio of 0.44 is 87.1% below the sector median of 3.4.Profitable over the last 12 months ›
Net income over the last 12 months was -$105.2M on revenue of $915.5M, a net margin of -11.5%.
Key statistics
The headline figures for TLRY.
As of October 26, 2026, TLRY trades at $2.72, with a market value of $401.98M.
What the numbers say
CleaRank Financial AI's reading of TLRY's valuation, growth and risks.
Tilray Brands Inc. (TLRY) has no meaningful P/E, because its earnings per share over the last 12 months are negative. Measured on sales, its P/S of 0.44 is 87.1% below the sector median of 3.4.
The company is losing money, with a net margin of -11.5% and an operating margin of -6.23%. Shareholders' capital earns -9.38%, below the sector median of 7.3%, measured as return on equity. Debt-to-equity of 0.23 rounds out the fundamentals.
TLRY's most recent quarterly report, dated October 8, 2026, showed earnings of -$0.02 a share against an estimate of -$0.14, so the result came in better than analysts had expected. Even so, the stock slid 1.39% in the next session.
Over its last 2 reports, TLRY topped the estimate 1 time, yet the stock fell in the first session after that beat. The consensus EPS estimate stands at -$0.13 for this fiscal year and $0.14 for next.
Day-to-day swings are the main risk to plan around. TLRY has moved 2.61% on an average session, and its beta against the S&P 500 is 1.92. For as long as the price stays under both moving averages, the downtrend remains a risk in its own right. The price is 82.68% below the 52-week high of $15.70.
TLRY against the Healthcare sector
How TLRY compares with the median Healthcare stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, TLRY trades at 0.4391x, far below the sector average of 3.40x.
Return vs XLV: Since May 14, 2025, TLRY has lost 38.2% against a gain of 39.2% for XLV.
Performance against XLV
TLRY and the Healthcare sector fund over the same days.
Revenue and earnings
How much TLRY sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to May 31, 2026); TLRY reported again on October 8, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 11.5% in FY2026 to $915M, from $821M a year earlier.
Profit margin: The net margin was -11.5% in FY2026, up from -265.6% the year before.
Loss-making: TLRY lost $105M in FY2026.
Earnings reality check
Did TLRY beat what analysts expected, and how did the stock react?
Earnings record: TLRY beat the analyst estimate in 1 of the last 2 quarters.
Market reaction: The stock fell in the first session after that beat, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 8, 2026after close | -$0.14 | -$0.02 | +85.71% | -1.39% | -10.58% |
| Apr 7, 2025after close | -$0.04 | -$0.10 | -150.00% | -20.69% | -15.52% |
As of October 26, 2026, TLRY has beaten the analyst EPS estimate in 1 of its last 2 reported quarters and fell in the first trading session after it; its latest report, on October 8, 2026, came in 85.71% above the estimate and the stock moved -1.39% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
TLRY AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 19.4, in oversold territory.RSI above 50 ›
An RSI of 19.4 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of TLRY
The score, the reasoning behind it, and what could move the price next.
Tilray Brands Inc. (TLRY) is in a downtrend: both moving averages lie above the price. The price of $2.72 sits 31.07% below the 50-day average of $3.95 and 51.49% below the 200-day average of $5.61. Within its 52-week range the stock is at 0%, and the price is 1.49% above the 52-week low of $2.68. The 50-day average is 29.62% below the 200-day, which backs up the weakness rather than undercutting it.
On momentum, the 14-day RSI reads 19.4, in oversold territory, with the MACD line negative. The recent returns all show a loss, with the price down 32.51% over the past three months, 60.52% over the past six months and 81.74% over the past year.
Earnings beat, but the stock fell ›
The October 8, 2026 report beat the EPS estimate by 85.71%, and the share price fell 1.39% in the first session after it.
Source: Earnings report, October 8, 2026Rating reaffirmed ›
Canaccord Genuity kept its Hold rating on October 9, 2026.
Source: Analyst action, Canaccord Genuity, October 9, 2026
- The two closest levels to monitor are the 20-day EMA at $3.28, which sits above the price, and the 52-week low at $2.68, which sits below it.
- With the 14-day RSI at 19.4, TLRY sits in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- Following the October 8, 2026 report, the share price dropped 1.39% in the first session. Over the last 2 reports, TLRY beat estimates in 1 of them.
The downtrend stays in place while TLRY is below both its 50-day average at $3.95 and its 200-day average at $5.61; a close back above the 50-day would be the first step of a repair. The 20-day EMA at $3.28 is the first hurdle overhead.
The next level below the price is the 52-week low at $2.68. The RSI is in oversold territory, so a recovery back above the oversold line would be the first hint that selling pressure is fading.
Technical indicators
Momentum and trend for TLRY, from its daily closes.
As of October 26, 2026, with TLRY at $2.72, its 14-day RSI is 19.4 (oversold territory), its 50-day simple moving average is $3.95 and its 200-day is $5.61.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What TLRY moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, TLRY's 1-year correlation of daily returns is +0.28 with S&P 500 (SPY), +0.25 with Nasdaq 100 (QQQ), +0.23 with Bitcoin (BTC) and +0.06 with gold (XAU).
TLRY price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
3 of 10 analysts rate it a buy or strong buy, 7 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $4.50 is 65.4% above the price.More buy ratings than three months ago ›
3 of 10 rate it a buy now, against 3 of 10 three months ago.
TLRY Wall Street View
12-month price targets
The price, $2.72, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | Canaccord Genuity | Maintains | Hold |
| Jul 14, 2026 | TD Cowen | Maintains | Buy |
As of October 26, 2026, 10 Wall Street analysts cover TLRY: 3 rate it a buy or strong buy, 7 a hold and 0 a sell or strong sell. Their 12-month price targets range from $4.00 to $12.00. The median TLRY price target is $4.50, 65.4% above the price of $2.72.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
TLRY trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
TLRY trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from TLRY's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much TLRY tends to move, against the market and on its own.
TLRY price history and drawdowns
TLRY's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.61% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 99.8%, from October 2018 to October 2026; the price is still 99.8% below that peak.Most 1-year holds ended higher ›
21% of 1-year holding periods in the last 8 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in July 2018 is now worth $121, against $30,935 in the S&P 500 (SPY).
TLRY Drawdowns & Recovery
As of October 26, 2026, TLRY's worst peak-to-trough fall over the period since July 2018 with dividends reinvested was -99.8% (October 2018 to October 2026); it is still 99.8% below that peak, and 21% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into TLRY in July 2018 is worth now, against the same amount in the S&P 500.
Against the market: TLRY trailed the S&P 500 over this period: $121.48 against $30,935.
A $10,000 investment in TLRY in July 2018 would be worth about $121 today with dividends reinvested, compared with about $30,935 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to TLRY, and which have not.
Strongest month, August: an average of +28.55%, up in 6 of 9 years.
Weakest month, April: an average of -20.05%, up in 0 of 8 years.
This month, October: has averaged -0.61%, up in 3 of 8 years. Past seasonality does not repeat on schedule.
Over the last 9 years, TLRY's strongest calendar month has been August (average +28.55%, up in 6 of 9 years) and its weakest April (average -20.05%, up in 0 of 8 years).
Average return for each calendar month over the last 9 years, from weekly closing prices with dividends included.
TLRY stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in TLRY, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 8 years of price history, projects that a $10,000 investment in TLRY today could grow to about $6,172 by 2030 in the base case, with a 90th-percentile outcome near $22,232 and a 10th-percentile outcome around $1,713. Projections are statistical simulations, not guarantees.
TLRY Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $1.68 for TLRY by 2030 in the base case, from $2.72 today (0.6x over 4 years). The 10th-percentile path ends near $0.466. These are outcomes of a Monte Carlo simulation run on TLRY's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $1.27 | $2.41 | $4.58 | |
| 2028 | $0.8634 | $2.14 | $5.29 | |
| 2029 | $0.6242 | $1.89 | $5.75 | |
| 2030 | $0.466 | $1.68 | $6.05 |
Method: a lognormal simulation of TLRY's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
TLRY insider trading
What the people running the company have bought and sold.
TLRY insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $193K on the open market and sold $233K.
As of October 26, 2026, TLRY insiders reported 1 open-market sale worth $233K and 6 open-market purchases worth $193K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Denise M Faltischek
Officer
|
Grant | 178.2K | - |
| Aug 26, 2026 | Mitchell S Gendel
General Counsel
|
Grant | 160.3K | - |
| Aug 26, 2026 | Carl A. Merton
Chief Financial Officer
|
Grant | 168.5K | - |
| Aug 26, 2026 | Irwin David Simon
Chief Executive Officer
|
Grant | 1.2M | - |
| Aug 6, 2026 | Mitchell S Gendel
Officer
|
Buy | 2.5K | $11.1K |
| Aug 4, 2026 | Carl A. Merton
Chief Financial Officer
|
Buy | 10.0K | $46.2K |
| Aug 3, 2026 | Denise M Faltischek
Officer
|
Buy | 2.5K | $12.0K |
| Jul 30, 2026 | Denise M Faltischek
Officer
|
Grant | 119.8K | - |
| Jul 30, 2026 | Mitchell S Gendel
Officer
|
Grant | 111.8K | - |
| Jul 30, 2026 | Carl A. Merton
Chief Financial Officer
|
Grant | 77.1K | - |
| Jul 30, 2026 | Irwin David Simon
Chief Executive Officer
|
Grant | 546.1K | - |
| Jul 29, 2026 | David F Clanachan
Director
|
Grant | 43.1K | - |
| Jul 29, 2026 | Steven Michael Cohen
Director
|
Grant | 43.1K | - |
| Jul 29, 2026 | Johann Michael Herhalt
Director
|
Grant | 43.1K | - |
| Jul 29, 2026 | David G. Hopkinson
Director
|
Grant | 43.1K | - |
| Jul 29, 2026 | Thomas Patrick Looney
Director
|
Grant | 43.1K | - |
| Jul 29, 2026 | Renah Persofsky
Director
|
Grant | 43.1K | - |
| Apr 21, 2026 | David G. Hopkinson
Director
|
Sell | 33.6K | $232.9K |
| Jan 7, 2026 | Steven Michael Cohen
Director
|
Option | 12.4K | $111.8K |
| Jul 31, 2025 | Denise M Faltischek
Officer
|
Option | 93.9K | $54.5K |
| Jul 31, 2025 | Mitchell S Gendel
General Counsel
|
Buy | 6.0K | $3.5K |
| Jul 31, 2025 | Mitchell S Gendel
General Counsel
|
Option | 93.9K | $54.5K |
| Jul 31, 2025 | Carl A. Merton
Chief Financial Officer
|
Option | 93.9K | $54.5K |
| Jul 31, 2025 | Irwin David Simon
Chief Executive Officer
|
Option | 706.2K | $409.6K |
| Jul 30, 2025 | David F Clanachan
Director
|
Option | 124.4K | $75.9K |
| Jul 30, 2025 | Denise M Faltischek
Officer
|
Grant | 261.2K | - |
| Jul 30, 2025 | Mitchell S Gendel
Officer
|
Option | 243.8K | $148.7K |
| Jul 30, 2025 | Johann Michael Herhalt
Director
|
Grant | 124.4K | - |
| Jul 30, 2025 | David G. Hopkinson
Director
|
Option | 124.4K | $75.9K |
| Jul 30, 2025 | Thomas Patrick Looney
Director
|
Grant | 124.4K | - |
| Jul 30, 2025 | Carl A. Merton
Chief Financial Officer
|
Option | 166.6K | $101.6K |
| Jul 30, 2025 | Carl A. Merton
Chief Financial Officer
|
Buy | 33.5K | $19.9K |
| Jul 30, 2025 | Renah Persofsky
Director
|
Option | 124.4K | $75.9K |
| Jul 30, 2025 | Irwin David Simon
Chief Executive Officer
|
Grant | 1.2M | - |
| Jul 30, 2025 | Irwin David Simon
Chief Executive Officer
|
Buy | 165.0K | $100.1K |
| Jun 2, 2025 | Denise M Faltischek
Officer
|
Option | 249.4K | $102.2K |
| Jun 2, 2025 | Mitchell S Gendel
Officer
|
Option | 231.2K | $94.8K |
| Jun 2, 2025 | Carl A. Merton
Chief Financial Officer
|
Option | 174.5K | $71.5K |
| Jun 2, 2025 | Irwin David Simon
Chief Executive Officer
|
Option | 1.2M | $483.0K |
Source: TwelveData, from reported insider filings
TLRY stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.